SCHEMBL29367262

SCHEMBL29367262

O=C1OC2(c3cc(F)c(O)cc3Oc3cc(O)c(F)cc32)c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.64
MEN1 O00255 5/20 0.64
KMT2A Q03164 5/20 0.64
TDP1 Q9NUW8 4/20 0.64
FTO Q9C0B1 3/20 0.64
HTT P42858 2/20 0.64
RECQL P46063 2/20 0.64
BLM P54132 2/20 0.64
PRMT1 Q99873 2/20 0.64
ACE2 Q9BYF1 2/20 0.64
CYP2C19 P33261 2/20 0.64
HPGD P15428 1/20 0.64
SMAD3 P84022 1/20 0.64
GNG2 P59768 1/20 0.53
GNB1 P62873 1/20 0.53
LMNA P02545 5/20 0.52
USP2 O75604 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CYP3A4 P08684 3/20 0.50
POLB P06746 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30218785 1.00 MAPT (0.64) MAPTMEN1KMT2ATDP1FTO
SCHEMBL408340 1.00 MAPT (0.64) MAPTMEN1KMT2ATDP1FTO
SCHEMBL3656821 0.93 FTO (0.79) MAPTMEN1KMT2ATDP1FTO
SCHEMBL10176068 0.91 MAPT (0.54) MAPTMEN1KMT2ATDP1FTO
SCHEMBL10145464 0.89 MAPT (0.53) MAPTMEN1KMT2ATDP1FTO
SCHEMBL31620935 0.88 MAPT (0.71) MAPTMEN1KMT2ATDP1FTO
SCHEMBL4933751 0.85 MAPT (0.63) MAPTMEN1KMT2ATDP1FTO
SCHEMBL7971498 0.84 FTO (0.69) MAPTMEN1KMT2ATDP1FTO
SCHEMBL7976347 0.84 FTO (0.55) MAPTMEN1KMT2ATDP1FTO
SCHEMBL22434195 0.84 MAPT (0.47) MAPTMEN1KMT2ATDP1FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608872-A2 SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION Slingshot Biosciences, Inc. (US) 2025-09-03 EP claimed
EP-4577823-A2 COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION Slingshot Biosciences, Inc. (US) 2025-07-02 EP claimed
CN-119744345-A Compositions and methods for single well multiple calibration and compensation 弹弓生物科学公司 2025-04-01 CN claimed
CN-119286363-A Anticorrosive paint, preparation method thereof, anticorrosive coating and application 南方电网科学研究院有限责任公司 2025-01-10 CN claimed
CN-119081529-A Super-hydrophobic coating, preparation method thereof, super-hydrophobic coating and application 广东电网有限责任公司湛江供电局 2024-12-06 CN claimed
WO-2024092161-A2 SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION SLINGSHOT BIOSCIENCES, INC. (US) 2024-05-02 WO claimed
WO-2024064962-A2 IMMUNO-PCR AND NEXT GENERATION SEQUENCING FOR PRECISE ANTIGEN QUANTITATION SLINGSHOT BIOSCIENCES, INC. (US) 2024-03-28 WO claimed
WO-2024044593-A2 COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION SLINGSHOT BIOSCIENCES, INC. (US) 2024-02-29 WO claimed
US-20260061069-A1 SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION SLINGSHOT BIOSCIENCES INC (US) 2026-03-05 US disclosed
US-20250389633-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE SLINGSHOT BIOSCIENCES, INC. (US) 2025-12-25 US disclosed
US-20250362292-A1 APOPTOTIC CELL MIMIC SLINGSHOT BIOSCIENCES, INC. (US) 2025-11-27 US disclosed
US-20250354204-A1 AUTOMATED RNA DETECTION USING LABELED 2'-O-METHYL RNA OLIGONUCLEOTIDE PROBES AND SIGNAL AMPLIFICATION SYSTEMS VENTANA MED SYST INC (US) 2025-11-20 US disclosed
US-20250340845-A1 METHOD OF PRODUCING STEM CELL-DERIVED ENDOTHELIAL CELLS AND USES THEREOF EMORY UNIVERSITY (US) 2025-11-06 US disclosed
US-12461007-B2 CD34 stem cell mimics SLINGSHOT BIOSCIENCES, INC. (US) 2025-11-04 US disclosed
CN-114539280-A Novel compound and structure for detecting hydrogen sulfide 佳能株式会社 2022-05-27 CN disclosed
CN-114480574-A Representative diagnosis 文塔纳医疗系统公司 2022-05-13 CN disclosed
EP-3976834-A1 DETECTION OF ANTIBIOTIC RESISTANCE GENES Streck, Inc. (US) 2022-04-06 EP disclosed
US-20220098676-A1 SINGLE-STRANDED OLIGONUCLEOTIDE PROBES FOR CHROMOSOME OR GENE COPY ENUMERATION VENTANA MEDICAL SYSTEMS, INC. 2022-03-31 US disclosed
EP-3956474-A1 METHODS FOR THE TREATMENT AND PROGNOSIS OF CANCER INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2022-02-23 EP disclosed
CN-108449995-B Representative diagnosis 文塔纳医疗系统公司 2022-02-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260061069-A1 SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION ICOS, CD47, CD4 MAPT 2952/4885MEN1 1162/4885KMT2A 2651/4885
US-20250389633-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE CD4, ICOS, CD69 MAPT 1949/4885MEN1 3203/4885KMT2A 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.